PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Trelegy Ellipta
- Generic name / active ingredient
- fluticasone furoate, umeclidinium and vilanterol
- Dosage-form class
- Three-ingredient dry-powder inhaler: 100 mcg/62.5 mcg/25 mcg or 200 mcg/62.5 mcg/25 mcg per inhalation (as listed in the current U.S. label)
- Route
- Oral inhalation
- Record reviewed
- 2026-08-19
Copy from the pack in hand
Source-linked reading points
- 100/62.5/25 and 200/62.5/25 mcg are complete three-ingredient markings per inhalation, not a formula a webpage can split, add or convert into an individual's inhalation use. Also check the device, NDC, pack count, target market and label version together.
- TRELEGY ELLIPTA is not self-combinable, alternatable, substitutable or device-shareable with VENTOLIN HFA, ANORO ELLIPTA, INCRUSE ELLIPTA, BREO ELLIPTA or another inhaler merely because labels mention inhalation, ELLIPTA or one shared ingredient.
- The current label states it is not indicated for relief of acute bronchospasm. Sudden or worsening breathing difficulty, chest pain, cyanosis, trouble speaking, fainting or another acute concern needs the local urgent-care plan and clinician guidance, not self-added, make-up or changed inhaler use from this page.
- Device opening, storage, cleaning, inhalation technique and remaining-dose counting must return to the patient instructions for the actual product and demonstration by a pharmacist/prescribing team; this page only helps locate the exact label and cannot replace device teaching.
Reviewed presentation examples — compare every field
- 100/62.5/25 mcg per labelled inhalation; one ELLIPTA inhaler (30 labelled inhalations; 60 blisters)NDC 0173-0887-10
- 200/62.5/25 mcg per labelled inhalation; one ELLIPTA inhaler (30 labelled inhalations; 60 blisters)NDC 0173-0893-10